Adenovirus Infection Clinical Trials

6 recruitingLast updated: July 25, 2026

There are 6 actively recruiting adenovirus infection clinical trials across 14 countries. Studies span Phase 2, Phase 1, Phase 3. Top locations include Columbus, Ohio, United States, Houston, Texas, United States, Chicago, Illinois, United States. Updated daily from ClinicalTrials.gov.


Adenovirus Infection Trials at a Glance

6 actively recruiting trials for adenovirus infection are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Columbus, Houston, and Chicago. Lead sponsors running adenovirus infection studies include SymBio Pharmaceuticals, M.D. Anderson Cancer Center, and Nationwide Children's Hospital.

Browse adenovirus infection trials by phase

About Adenovirus Infection Clinical Trials

Looking for clinical trials for Adenovirus Infection? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Adenovirus Infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Adenovirus Infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Phase 1Phase 2

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

TuberculosisEBV InfectionAdenovirus Infection+4 more
Shenzhen Geno-Immune Medical Institute100 enrolled1 locationNCT03159364
Recruiting
Phase 3

A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT

Adenovirus Infections
SymBio Pharmaceuticals180 enrolled61 locationsNCT07387367
Recruiting
Phase 1

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmSymptomatic COVID-19 Infection Laboratory-Confirmed+4 more
M.D. Anderson Cancer Center30 enrolled1 locationNCT05101213
Recruiting
Phase 1Phase 2

Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections

Adenovirus Infection
Nationwide Children's Hospital12 enrolled1 locationNCT04722029
Recruiting
Phase 2

A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®

Cytomegalovirus InfectionsAdenovirus InfectionEBV+2 more
University Hospital, Basel, Switzerland30 enrolled1 locationNCT02007356
Recruiting
Phase 2

A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection

cytomegalovirus infectionAdenovirus Infections
SymBio Pharmaceuticals52 enrolled11 locationsNCT04706923